Shares in Galapagos jump 15 percent after arthritis drug results

Shares in Belgian drugmaker Galapagos surged nearly 16 percent on Friday after the company said it had seen positive results from several safety and efficacy trials of its rheumatoid arthritis drug filgotinib.

from Reuters: Health News https://ift.tt/2V2RAJt
via IFTTT